Compare Edwards Lifesciences Corporation Common Stock (EW) vs Franklin FTSE South Korea ETF (FLKR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Franklin FTSE South Korea ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while Franklin FTSE South Korea ETF trades at $58.12 (market cap $1.83B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 26.5× Franklin FTSE South Korea ETF's market cap, and Franklin FTSE South Korea ETF is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | FLKR | |
|---|---|---|
Market Cap | $48.56B | $1.83B |
Volume | 6,520,488 | 679,902 |
Sector | Health | Broad Market / Factor |
52-Week High | $95.18 | $72.25 |
52-Week Low | $72.65 | $27.09 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 15 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →
